Nutex Health Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 62.72 million compared to USD 28.4 million a year ago. Net loss was USD 5.54 million compared to USD 412.19 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.62 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.62 a year ago.
For the nine months, revenue was USD 177.98 million compared to USD 165.57 million a year ago. Net loss was USD 14.17 million compared to USD 410.03 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.65 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.65 a year ago.